Please provide your email address to receive an email when new articles are posted on . There are no FDA-approved medications for post-traumatic headache. Most patients reported treatment had a ...

Another earlier memantine trial – the Benefit and Efficacy in Severely Demented patients during Treatment with Memantine (M-Best or 9403) study – enrolled participants with moderately severe AD as ...

Deprescribing ChEIs/memantine can reduce the risk for ADRs and drug-drug and drug-disease interactions. It can also reduce the pill burden for patients and improve adherence to other medications, as ...

Elevated pregenual anterior cingulate cortex levels were associated with a favorable treatment response. HealthDay News — Memantine improves social impairments in youth with autism spectrum disorder ...

For decades, dementia, especially Alzheimer’s disease, was treated as untouchable. Families watched loved ones fade, doctors could offer only reassurance and coping strategies, and research seemed to ...

Memantine has demonstrated efficacy in suppressing premature atrial contractions in a phase II trial. The study showed a reduction in both atrial ectopy and overall atrial tachyarrhythmia ...

Please provide your email address to receive an email when new articles are posted on . Response rates on the SRS-2 and CGI-S were significantly higher in those given memantine. Memantine was also ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

TUESDAY, Oct. 7, 2025 (HealthDay News) -- Memantine improves social impairments in youth with autism spectrum disorder (ASD), according to a study published online Oct. 1 in JAMA Network Open. Gagan ...